TILseg: Automated Whole Slide-Level Spatial Scoring of Tumor-Infiltrating Lymphocytes Reveals Prognostic Patterns in Triple Negative Breast Cancer
Carr, L. L.; Sankaranarayanan, A.; Ha, K.; Rawlani, M.; Kazerouni, A. S.; Specht, J.; Kennedy, L. C.; Reiter, D.; Dintzis, S.; Hippe, D. S.; Kilgore, M. R.; Symonds, L.; Partridge, S. C.; Mittal, S.
Show abstract
Stromal tumor-infiltrating lymphocytes (sTILs) are promising biomarkers for predicting therapeutic outcomes in triple-negative breast cancer (TNBC), with higher sTIL levels correlating with improved chemotherapy response and survival outcomes. Currently, sTILs are manually evaluated by pathologists, which is prone to inter-reader variability. In this study, we have developed an AI-driven TIL segmentation pipeline to process entire diagnostic hematoxylin-and-eosin-stained whole slide images for reproducible scoring (global TILseg scoring) and reliable prognostication. This pipeline was optimized and tested using two independent TNBC patient cohorts (n = 57 in the discovery cohort, n = 43 in the validation cohort) with clinical outcomes and follow-up data. The global scores generated by TILseg showed moderate to high concordance with expert scoring (Spearman R = 0.84-0.89) and improved patient stratification (p-value = 0.0191) as compared to manual scoring (p-value = 0.0663). Additionally, we investigate how the spatial localization of sTILs (spatial TILseg) impact survival outcomes by identifying TILs in selected stromal subsets (0.02-2 mm from the epithelial clusters). Our findings have shown that TILs up to 50 {micro}m from epithelial regions prove to be most prognostic in predicting recurrence-free survival post-neoadjuvant chemotherapy with higher statistical significance than both manual and global TILseg scoring. Further, spatial TILseg scoring was more significantly associated with pathological complete response status in both patient cohorts. In summary, we present an AI-based digital tool for robust sTIL scoring and spatial mapping to enhance its potential as both a diagnostic and prognostic biomarker, particularly in TNBC patients. SIGNIFICANCEAn automated and spatially resolved AI tool for sTILs scoring enhances patient risk stratification based on both response to treatment and recurrence-free survival, establishing its relevance as an independent prognostic marker.
Matching journals
The top 6 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Unmasking the tissue microecology of ductal carcinoma in situ with deep learning 96%
- Normal Breast Tissue (NBT)-Classifiers: Advancing Compartment Classification in Normal Breast Histology 95%
- The clinical and molecular significance associated with STING signaling in estrogen receptor-positive early breast cancer 95%
Similar papers in this journal
- Integrated radiogenomics models predict response to neoadjuvant chemotherapy in high grade serous ovarian cancer 96%
- Multiplexed RNA-FISH-guided Laser Capture Microdissection RNA Sequencing Improves Breast Cancer Molecular Subtyping, Prognostic Classification, and Predicts Response to Antibody Drug Conjugates 95%
- Integrative spatial omics reveals distinct tumor-promoting multicellular niches and immunosuppressive mechanisms in Black American and White American patients with TNBC 95%
Similar papers in this journal
- Automated quantification of Ki-67 expression in breast cancer from H&E-stained slides using a transformer-based regression model 95%
- Development and prognostic validation of a three-level NHG-like deep learning-based model for histological grading of breast cancer 95%
- Mutational landscape of pure ductal carcinoma in situ and associations with disease prognosis and response to radiotherapy 95%
Similar papers in this journal
- Image-Based Consensus Molecular Subtyping in Rectal Cancer Biopsies and Response to Neoadjuvant Chemoradiotherapy 95%
- Single-Cell Spatial Proteomics Analyses of Head and Neck Squamous Cell Carcinoma Reveal Tumor Heterogeneity and Immune Architectures Associated with Clinical Outcome 95%
- Development and validation of a gene expression score to account for tumour purity and improve prognostication in breast cancer 95%
Similar papers in this journal
- Myeloid cell-associated resistance to PD-1/PD-L1 blockade in urothelial cancer revealed through bulk and single-cell RNA sequencing 94%
- Tamoxifen Response at Single Cell Resolution in Estrogen Receptor-Positive Primary Human Breast Tumors 93%
- Circulating tumor DNA analysis in advanced urothelial carcinoma: insights from biological analysis and extended clinical follow-up 93%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.